Skip to main content
SpringerLink
Log in

Fatigue in multiple sclerosis

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Fatigue is among the most common, yet least understood, symptoms of multiple sclerosis (MS) [1·]. It can profoundly disrupt the occupational and social functioning of patients, and is recognized as a criterion for MS disability by the Social Security Administration. Most approaches to fatigue assessment can be classified as either self-report scales or performance-based measures of motor or cognitive output. During the clinical management of fatigue, it is important to consider the role of other MS symptoms on fatigue, as well as that of non—MS-related medical conditions. Management of fatigue in MS often entails both pharmacologic and behavioral components. This article reviews recent developments in the assessment, treatment, and pathogenesis of MS fatigue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and Multiple Sclerosis: Evidence-based Management Strategies for Fatigue in Multiple Sclerosis. Washington DC: Paralyzed Veterans of America, 1998. This is a comprehensive review of current knowledge on fatigue in multiple sclerosis. The manual summarizes an evaluation and treatment algorithm and provides directions for future research.

    Google Scholar 

  2. Freal J, Kraft G, Coryell J: Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 1984, 65:135–138.

    PubMed  CAS  Google Scholar 

  3. Murray T: Amantadine therapy for fatigue in multiple sclerosis. Can J Neural Sci 1985, 12:251–254.

    CAS  Google Scholar 

  4. Krupp L, Alvarez L, LaRocca N, Scheinberg L: Clinical characteristics of fatigue in multiple sclerosis. Arch Neurol 1988, 45:435–437.

    PubMed  CAS  Google Scholar 

  5. Schwartz CE, Coulthard Morris L, Zeng Q: Psychosocial correlates of fatigue in multiple sclerosis. Arch Phys Med Rehabil 1996, 77:165–170.

    Article  PubMed  CAS  Google Scholar 

  6. Vercoulen J, Hommes O, Swanink C, et al.: The measurement of fatigue in patients with multiple sclerosis: a multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol 1996, 53:642–649.

    PubMed  CAS  Google Scholar 

  7. Provinciali L, Ceravolo M, Bartolini M, et al.: A multidimensional assessment of multiple sclerosis: relationships between disability domains. Acta Neurol Scand 1999, 100:156–162.

    Article  PubMed  CAS  Google Scholar 

  8. Code of Federal Regulations, Title 20—Employees’ Benefits, Chapter III - Social Security Administration, Part 404 - Federal Old-Age, Survivors and Disability Insurance (1950-), Subpart P - Determining Disability and Blindness, Appendix 1 to Subpart P of Part 404 — Listing of Impairments, Part A.

  9. Fisk J, Pontefract A, Ritvo P, et al.: The impact of fatigue on patients with multiple sclerosis. Can J Neural Sci 1994, 21:9–14.

    CAS  Google Scholar 

  10. Iriarte J, Katsamakis G, De Castro P: The fatigue descriptive scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis. Mult Scler 1999, 5:10–16.

    PubMed  CAS  Google Scholar 

  11. Krupp L, La Rocca N, Muirnash J, Steinberg A: The fatigue severity scale-application to patients with multiple sclerosis and systemic lupus-erythematosus. Arch Neurol 1989, 46:1121–1123.

    PubMed  CAS  Google Scholar 

  12. Belza B, Henke C, Yelin E, et al.: Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 1993, 42:93–99.

    Article  PubMed  CAS  Google Scholar 

  13. Smets E, Garssen B, Bonke B, De Haes J: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39:315–325.

    Article  PubMed  CAS  Google Scholar 

  14. Schwartz J, Jandorf L, Krupp LB: The measurement of fatigue: a new scale. J Psychosom Res 1993, 37:753–762.

    Article  PubMed  CAS  Google Scholar 

  15. Chalder T, Berelowitz G, Pawlikowska T, et al.: Development of a fatigue scale. J Psychosom Res 1993, 37:147–153.

    Article  PubMed  CAS  Google Scholar 

  16. Sheean GL, Murray NM, Rothwell JC, et al.: An open-labeled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis. Brain 1998, 121:967–975. This study demonstrates how treatment with 3,4 diaminopyridine differentially affects a performance-based measure of fatigue (electrophysiologic test) from a self-report assessment of fatigue (fatigue severity scale).

    Article  PubMed  Google Scholar 

  17. Rammohan K, Rosenberg JH, Pollak CP, et al.: Modafinil-efficacy and safety for the treatment of fatigue in patients with multiple sclerosis [abstract]. Neurology 2000, 54(suppl 3):A24.

    Google Scholar 

  18. Fischer J, La Rocca N, Miller D, et al.: Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler 1999, 5:251–259.

    PubMed  CAS  Google Scholar 

  19. Ware J, Kosinski M, Keller S: SF-36 Physical and Mental Health Summary Scales: A User’s Manual. Boston: The Health Institute, New England Medical Center; 1994.

    Google Scholar 

  20. McNair D, Lorr M, Droppleman L: Profile of mood states. San Diego: Educational and Industrial Testing Service; 1992.

    Google Scholar 

  21. Taylor RR, Jason LA, Torres A: Fatigue rating scales: an empirical comparison. Psychol Med 2000, 30:849–856. The relative strengths of two fatigue scales are evaluated in control patients and individuals with chronic fatigue syndrome with respect to their psychometric properties and correlation to measures of quality of life using the SF-36.

    Article  PubMed  CAS  Google Scholar 

  22. Schwid S, Thornton C, Pandya S, et al.: Quantitative assessment of motor fatigue and strength in MS. Neurology 1999, 53:743–750. Strength and motor fatigue can be measured reliably in multiple sclerosis with a protocol involving sustained contractions, repetitive contractions, and ambulation.

    PubMed  CAS  Google Scholar 

  23. Djaldetti R, Ziv I, Achiron A, Melamed E: Fatigue in multiple sclerosis compared with chronic fatigue syndrome: a quantitative assessment. Neurology 1996, 46:632–635.

    PubMed  CAS  Google Scholar 

  24. Sharma K, Kent-Braun J, Mynhier M: Evidence of an abnormal intramuscular component of fatigue in multiple sclerosis. Muscle Nerve 1995, 18:1403–1411.

    Article  PubMed  CAS  Google Scholar 

  25. Sheean G, Murray NM, Rothwell J, et al.: An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 1997, 120:299–315.

    Article  PubMed  Google Scholar 

  26. Kent-Braun J, Sharma K, Miller R, Weiner M: Postexercise phosphocreatine resynthesis is slowed in multiple sclerosis. Muscle Nerve 1994, 17:835–841.

    Article  PubMed  CAS  Google Scholar 

  27. Latash M, Kalugina E, Nicholas J, et al.: Myogenic and central neruogenic factors in fatigue in multiple sclerosis. Mult Scler 1996, 1:236–241.

    PubMed  CAS  Google Scholar 

  28. Schubert M, Wohlfarth K, Rollnick J, Dengler R: Walking and fatigue in multiple sclerosis: the role of the corticospinal system. Muscle Nerve 1998, 21:1068–1070.

    Article  PubMed  CAS  Google Scholar 

  29. Kujala P, Portin R, Reconsuo A, Ruutiainen J: Attention related performance in two cognitively different subgroups of patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1995, 59:77–82.

    Article  PubMed  CAS  Google Scholar 

  30. Krupp LB, Elkins LE: Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000, 55:934–939. Cognitive fatigue, defined as a decline in cognitive performance during a single testing session, can be identified in multiple sclerosis and distinguished from the pattern observed in control patients.

    PubMed  CAS  Google Scholar 

  31. Logan G, Klapp S: Automatizing alphabet arithmetic: I. Is extended practice necessary to produce automaticity? J Exp Psychol: Learning, Memory, Cognition 1991, 17:179–195.

    Article  Google Scholar 

  32. Johnson SK, Lange G, DeLuca J, et al.: The effects of fatigue on neuropsychological performance in patients with chronic fatigue syndrome, multiple sclerosis, and depression. Appl Neuropsychol 1997, 4:145–153.

    Article  PubMed  CAS  Google Scholar 

  33. Paul RH, Beatty WW, Schneider R, et al.: Impairments of attention in individuals with multiple sclerosis. Mult Scler 1998, 4:433–439.

    PubMed  CAS  Google Scholar 

  34. Heilman K, Watson R: Fatigue. Neurol Network Comm 1997, 1:283–287.

    Google Scholar 

  35. Newsholme EA, Blomstrand E: The plasma level of some amino acids and physical and mental fatigue. Experientia 1996, 52:413–415.

    Article  PubMed  CAS  Google Scholar 

  36. Bakshi R, Miletich R, Henschel K, et al.: Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology 1999, 53:1151–1153. An extensive analysis of magentic resonance imaging (MRI) measures in 71 multiple sclerosis (MS) patients with and without fatigue concludes that MRI disease topography and severity do not explain MS fatigue.

    PubMed  CAS  Google Scholar 

  37. Mainero C, Faroni J, Gasperini C, et al.: Fatigue and magnetic resonance imaging activity in multiple sclerosis. J Neurol 1999, 246:454–458.

    Article  PubMed  CAS  Google Scholar 

  38. Van Der Werf S, Jongen P, Lycklama a Nijeholt G, et al.: Fatigue in multiple sclerosis: inter-relations between fatigue complaints, cerebral MRI abnormalities and neurological disability. J Neurol Sci 1998, 160:164–170.

    Article  PubMed  Google Scholar 

  39. Moller A, Wiedemann G, Rohde U, et al.: Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatrica Scand, 1994, 89:117–121.

    CAS  Google Scholar 

  40. Roelcke U, Kappos L, Lechner-Scott J, et al.: Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 1997, 48:1566–1571.

    PubMed  CAS  Google Scholar 

  41. Quesada J, Talpaz M, Rios A, et al.: Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 1986, 4:234–243.

    PubMed  CAS  Google Scholar 

  42. Neilley L, Goodlin D, Goodkin D, Hauser S: Side effect profile of interferon-beta 1b in MS results of an open label trial. Neurology 1996, 46:552–554.

    PubMed  CAS  Google Scholar 

  43. Jones T, Wadler S, Hupart K: Endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha. Semin Oncol 1998, 25(suppl 1):54–63.

    PubMed  CAS  Google Scholar 

  44. Martinez-Caceres E, Rio J, Barrau M, et al.: Amelioration of flulike symptoms at the onset of interferon B-1b therapy in multiple sclerosis by low-dose oral steroids is related to a decrease in interleukine-6 induction. Ann Neurol 1998, 44:682–685.

    Article  PubMed  CAS  Google Scholar 

  45. Bakshi R, Shaikh ZA, Miletich RS, et al.: Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 2000, 6:181–185.

    PubMed  CAS  Google Scholar 

  46. Kroencke DC, Lynch SG, Denney DR: Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler 2000, 6:131–136.

    PubMed  CAS  Google Scholar 

  47. Pepper C, Krupp LB, Friedberg F: A comparison of psychiatric characteristics in chronic fatigue syndrome, multiple sclerosis and depression. J Neuropsychiatry Clin Neurosci 1993, 5:200–205.

    PubMed  CAS  Google Scholar 

  48. Krupp LB, Coyle PK, Doscher C, et al.: Fatigue therapy in multiple sclerosis: results of a double blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 1995, 45:1956–1961.

    PubMed  CAS  Google Scholar 

  49. Weinshenker BG, Penman M, Bass B, et al.: A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 1992, 42:1468–1471.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, State University of New York at Stony Brook, HSC-T12-020, 11794-8121, Stony Brook, NY, USA

    Lauren B. Krupp MD & Christopher Christodoulou PhD

Authors
  1. Lauren B. Krupp MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher Christodoulou PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krupp, L.B., Christodoulou, C. Fatigue in multiple sclerosis. Curr Neurol Neurosci Rep 1, 294–298 (2001). https://doi.org/10.1007/s11910-001-0033-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-001-0033-7

Keywords

Search

Navigation